锦好医疗
(920925)
| 流通市值：6.14亿 | | | 总市值：10.94亿 |
| 流通股本：5529.51万 | | | 总股本：9858.06万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 105,680,614.14 | 41,924,051.86 | 307,521,692.87 | 195,653,829.77 |
| 营业总成本 | 113,454,456.02 | 49,206,673.72 | 287,329,520.29 | 178,671,183.5 |
| 其他经营收益 | | | | |
| 营业利润 | -6,036,207.41 | -6,345,810.11 | 15,660,848.52 | 17,358,407.51 |
| 利润总额 | -5,941,306.37 | -6,363,770.95 | 17,570,958.71 | 19,299,498.55 |
| 净利润 | -6,710,116.06 | -7,212,300.82 | 14,787,500.67 | 16,222,864.21 |
| 每股收益 | | | | |
| 其他综合收益 | 1,077,360.41 | 922,318.76 | -838,276.61 | -7,913.04 |
| 综合收益总额 | -5,632,755.65 | -6,289,982.06 | 13,949,224.06 | 16,214,951.17 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 215,362,396.19 | 211,939,292.58 | 218,842,140.32 | 240,451,786.86 |
| 非流动资产: | | | | |
| 非流动资产合计 | 217,186,329.39 | 218,622,751.1 | 221,509,240.28 | 257,837,631.87 |
| 资产总计 | 432,548,725.58 | 430,562,043.68 | 440,351,380.6 | 498,289,418.73 |
| 流动负债: | | | | |
| 流动负债合计 | 64,717,451.75 | 60,065,631.26 | 64,541,452.51 | 120,494,079.98 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,772,276.36 | 3,440,895.52 | 3,986,212.44 | 5,166,332.63 |
| 负债合计 | 68,489,728.11 | 63,506,526.78 | 68,527,664.95 | 125,660,412.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 363,921,695.65 | 366,700,970.42 | 370,952,726.69 | 372,593,954.75 |
| 股东权益合计 | 364,058,997.47 | 367,055,516.9 | 371,823,715.65 | 372,629,006.12 |
| 负债和股东权益合计 | 432,548,725.58 | 430,562,043.68 | 440,351,380.6 | 498,289,418.73 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 125,013,212.55 | 55,098,514.94 | 286,265,560.27 | 201,375,003.1 |
| 经营活动现金流出小计 | 120,443,210.9 | 65,390,253.85 | 269,914,093.62 | 185,974,754.2 |
| 经营活动产生的现金流量净额 | 4,570,001.65 | -10,291,738.91 | 16,351,466.65 | 15,400,248.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 78,167,132.55 | 30,283,297.95 | 186,490,728.2 | 131,007,973.98 |
| 投资活动现金流出小计 | 109,133,407.45 | 27,432,374.84 | 179,270,286.49 | 159,027,515.75 |
| 投资活动产生的现金流量净额 | -30,966,274.9 | 2,850,923.11 | 7,220,441.71 | -28,019,541.77 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 11,754,000 | 11,754,000 | 10,962,500 | 10,962,500 |
| 筹资活动现金流出小计 | 980,291.95 | 479,376.85 | 37,788,196.29 | 8,052,978.38 |
| 筹资活动产生的现金流量净额 | 10,773,708.05 | 11,274,623.15 | -26,825,696.29 | 2,909,521.62 |
| 汇率变动对现金及现金等价物的影响 | -2,388,596.68 | -804,412.51 | -178,463.52 | 533,734.92 |
| 现金及现金等价物净增加额 | -18,011,161.88 | 3,029,394.84 | -3,432,251.45 | -9,176,036.33 |
| 期末现金及现金等价物余额 | 36,723,797.68 | 57,764,354.4 | 54,734,959.56 | 47,433,530.64 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -18,011,161.88 | - | -3,432,251.45 | - |